BETA


2023/2703(RSP) Resolution on EU action to combat antimicrobial resistance

Progress: Procedure completed

Legal Basis:
RoP 136-p1

Events

2023/06/01
   EP - Oral question/interpellation by Parliament
Documents
2023/06/01
   EP - Debate in Parliament
2023/06/01
   EP - Decision by Parliament
Details

The European Parliament adopted by 525 votes to 2, with 33 abstentions, a resolution on EU action to combat antimicrobial resistance.

The text adopted in plenary was tabled by the EPP, S&D, Renew, Greens/EFA, ECR and the Left groups.

Context

In 2022, the Commission, together with the Member States, identified antimicrobial resistance (AMR) as one of the top three priority health threats in the EU. It is estimated that more than 35 000 people in the EU/EEA and more than 1.2 million people globally die each year as a direct consequence of an infection due to bacteria resistant to antibiotics. The health impact of AMR is comparable to that of influenza, tuberculosis and HIV/AIDS combined and the trends in the latest data show a significant increase in the number of infections and attributable deaths for almost all bacterium-antibiotic resistance combinations, especially in healthcare settings, where around 70 % of cases of infections with antibiotic-resistant bacteria were healthcare-associated infections.

If no further action is taken, the global AMR death toll by 2050 could reach more than 10 million annually, higher than the expected number of deaths from cancer and diabetes combined and could cause economic damage as catastrophic as the 2008-2009 global financial crisis.

Although AMR affects the Member States differently, action at EU level to address AMR can deliver clear added value, since no single Member State alone can provide an adequate solution to this cross-border and global issue.

Recommendations

Parliament is convinced that AMR requires a multi-faceted strategy in the EU, based on the One Health approach. It welcomed the Commission’s proposal for a Council recommendation on stepping up EU measures to combat antimicrobial resistance based on the One Health approach and called on the Council to adopt a recommendation taking this resolution into account as a way to step up action in areas complementing legislation under the proposed pharmaceuticals package. The resolution recalled however that powers to adopt binding Union acts in the field of health remain subject to the ordinary legislative procedure. Therefore, Parliament takes the view that should measures achieved under a recommendation be insufficient, further legislative action at EU level will be needed.

The resolution stressed that addressing AMR successfully requires a three-pronged approach combining prudent use of antibiotics for humans and animals, implementing good infection prevention and control measures, especially in healthcare settings and promoting research and development into novel antimicrobials and alternatives to antimicrobials.

National action plans against AMR

Parliament called on Member States to put in place, publicise and implement a national action plan against AMR (NAP), based on the One Health approach and in line with the objectives of the World Health Organization Global Action Plan and the 2016 Declaration of the United Nations high-level meeting of the General Assembly on AMR by 1 March 2024, and regularly update such the National Action Plans. Member States should ensure that appropriate and sufficient human and financial resources should be allocated for the effective implementation of the NAP.

Surveillance and monitoring of AMR and antimicrobial consumption (AMC)

Member States should close existing surveillance and monitoring gaps and ensure the completeness of the data, including real-time data where appropriate, by 2030, both on AMR and AMC at all levels (such as in the community, hospitals and long-term care facilities) to support the prudent use of antimicrobials in human health.

Infection prevention and control, and water, sanitation and hygiene

Parliament called on the Member States to ensure that infection prevention and control measures in human health are implemented and continuously monitored to contribute to limiting the spread of antimicrobial resistant pathogens in particular by strengthening infection prevention and control and improving WASH, environmental cleaning and waste management in healthcare settings and long-term care facilities and upgrading existing hospital infrastructure and human resources.

Moreover, measures should be taken to improve the health and welfare of food-producing animals to decrease the occurrence and spread of infectious diseases in farming. In this regard, the Commission is called on to put forward a proposal for the revision of EU legislation on farm animal welfare.

Parliament insisted that EU infection prevention and control guidelines in human health, notably for hospitals and long-term care facilities need to be put in place by 1 June 2026.

Antimicrobial stewardship and prudent use of antimicrobials

Parliament called on the Member States to ensure that human-health measures are implemented to support the prudent use of antimicrobial agents, inter alia by: (i) implementing EU guidelines for the treatment of common infections and for perioperative prophylaxis and adapting these guidelines to national circumstances, where necessary, in order to adhere to best practices and optimise the prudent use of antimicrobials; (ii) where possible, restricting antibiotic prescription to face-to-face consultations.

Member States are called on to put in place programmes for the collection and safe disposal of unused, expired and leftover antimicrobials from the community, hospitals and long-term care facilities, farms, veterinary medicine providers, and production facilities, and ensure that the public can make use of these disposal facilities via a local healthcare facility.

The Commission should work towards the development of EU guidelines for the treatment of major common infections in humans and for perioperative prophylaxis in humans.

Recommended targets for antimicrobial consumption and antimicrobial resistance

Member States are called on to take national measures to ensure that by 2030:

- the total consumption of antibiotics by humans (in terms of the defined daily dose (DDD) per 1 000 inhabitants), in the community and hospital sectors combined, including in long-term care facilities, is reduced by 20 % in the EU compared with the baseline year 2019 with a highest DDD of 15 in any Member State;

- at least 70 % of the total human consumption of antibiotics belongs to the Access group of antibiotics, as defined in the WHO’s AWaRe classification;

- the total incidence of bloodstream infections with methicillin-resistant Staphylococcus aureus (MRSA) (per 100 000 population) is reduced by 15 % in the EU, compared to the baseline year 2019;

- the total incidence of bloodstream infections with third generation cephalosporin-resistant Escherichia coli (per 100 000 population) is reduced by 10 % in the EU, compared to the baseline year 2019;

- the total incidence of bloodstream infections with carbapenem-resistant Klebsiella pneumoniae (per 100 000 population) is reduced by 5 % in the EU, compared to the baseline year 2019.

Research and development

Parliament called on the Member States and the Commission to:

- support research data sharing and technological innovation for the detection, prevention and treatment of infections in humans caused by antimicrobial resistant pathogens, including the establishment of, and significant investment in, a European partnership to allow coordination, alignment and funding of cross-sector research and innovation on ‘One Health AMR’;

- pool resources, run collaborative initiatives, financially contribute to the implementation of the pull incentive scheme, and undertake to participate in the network referred to under the EU4Health work programme 2023;

- incentivise the development and placing on the market of alternatives to antimicrobials, as well as innovative diagnostic tests and vaccines for animal health and alternatives to antimicrobials, such as local anaesthetics or psychopharmacological drugs, including a design for degradable antibiotics.

Reporting

The Commission should report to the European Parliament and the Council four years after adoption of this resolution on the progress in its implementation.

Documents
2023/05/24
   EP - Motion for a resolution
Documents

Documents

Votes

Action coordonnée pour lutter contre la résistance aux antimicrobiens - B9-0258/2023 - § 6, avant le point a - Am 5 #

2023/06/01 Outcome: -: 315, +: 255, 0: 46
IT PL CZ HU LV IE HR SI SK AT SE EL RO LT CY LU ?? BG FI EE MT PT NL DE BE DK FR ES
Total
61
49
18
20
7
12
11
7
12
16
21
11
29
10
5
5
1
16
13
7
5
20
26
79
21
13
68
53
icon: PPE PPE
152

Hungary PPE

Against (1)

1

Cyprus PPE

2

Luxembourg PPE

2

Estonia PPE

For (1)

1

Malta PPE

For (1)

1

Belgium PPE

4
icon: ID ID
58

Czechia ID

2
3

Estonia ID

For (1)

1

Denmark ID

For (1)

1
icon: ECR ECR
62

Latvia ECR

Abstain (1)

1

Croatia ECR

Abstain (1)

1

Slovakia ECR

For (1)

1

Sweden ECR

3

Greece ECR

1

Romania ECR

1

Lithuania ECR

Abstain (1)

1

Bulgaria ECR

2

Germany ECR

Abstain (1)

1
icon: NI NI
32

Latvia NI

1

Croatia NI

Abstain (1)

2

Slovakia NI

2

Greece NI

Against (1)

1

Lithuania NI

1

Netherlands NI

Against (1)

1

Germany NI

Against (1)

1

Belgium NI

Against (1)

1

France NI

2
icon: The Left The Left
28

Ireland The Left

Against (1)

3

Sweden The Left

Against (1)

1
3

Cyprus The Left

2

Finland The Left

Against (1)

1

Germany The Left

3

Belgium The Left

Against (1)

1

Denmark The Left

Against (1)

1
icon: Verts/ALE Verts/ALE
67

Italy Verts/ALE

3

Poland Verts/ALE

Against (1)

1

Czechia Verts/ALE

3

Ireland Verts/ALE

2

Austria Verts/ALE

3

Sweden Verts/ALE

3

Romania Verts/ALE

Against (1)

1

Lithuania Verts/ALE

2

Luxembourg Verts/ALE

Against (1)

1

Finland Verts/ALE

3

Portugal Verts/ALE

Against (1)

1

Netherlands Verts/ALE

3

Belgium Verts/ALE

3

Denmark Verts/ALE

2

Spain Verts/ALE

4
icon: Renew Renew
91

Italy Renew

Against (2)

2

Czechia Renew

Against (1)

Abstain (1)

4

Hungary Renew

2

Latvia Renew

Against (1)

1

Ireland Renew

2

Croatia Renew

Against (1)

1

Slovenia Renew

Against (1)

1

Slovakia Renew

3

Austria Renew

Against (1)

1
3

Greece Renew

Against (1)

1

Lithuania Renew

Against (1)

1

Luxembourg Renew

Against (1)

1

Bulgaria Renew

3

Finland Renew

3

Estonia Renew

3
icon: S&D S&D
126

Czechia S&D

Against (1)

1

Latvia S&D

For (1)

1

Slovenia S&D

2
3

Greece S&D

Against (1)

1

Lithuania S&D

2

Cyprus S&D

Against (1)

1

Luxembourg S&D

Against (1)

1

S&D

Against (1)

1

Finland S&D

Against (1)

1

Estonia S&D

2

Belgium S&D

2

B9-0258/2023 - § 10, partie introductive - Am 6 #

2023/06/01 Outcome: -: 468, +: 82, 0: 61
HU ?? LV MT EE CY LU CZ SK HR LT SI IE IT AT BE DK EL FI BG SE NL PT PL FR RO ES DE
Total
19
1
7
4
7
5
5
18
12
11
10
7
12
61
16
20
13
12
13
16
21
26
20
47
67
29
52
80
icon: ID ID
58

Estonia ID

For (1)

1

Czechia ID

2
3

Denmark ID

For (1)

1
icon: NI NI
31

Latvia NI

1

Slovakia NI

2

Croatia NI

Abstain (1)

2

Lithuania NI

1

Greece NI

Against (1)

1

Netherlands NI

Against (1)

1

France NI

2

Germany NI

Against (1)

1
icon: ECR ECR
60

Latvia ECR

Abstain (1)

1

Slovakia ECR

Abstain (1)

1

Croatia ECR

Abstain (1)

1

Lithuania ECR

Abstain (1)

1

Greece ECR

Abstain (1)

1

Finland ECR

2

Bulgaria ECR

2

Sweden ECR

3

Romania ECR

Abstain (1)

1

Germany ECR

Abstain (1)

1
icon: The Left The Left
28

Cyprus The Left

2

Ireland The Left

Against (1)

3

Belgium The Left

Against (1)

1

Denmark The Left

Against (1)

1

Finland The Left

Against (1)

1

Sweden The Left

Against (1)

1

Germany The Left

3
icon: Verts/ALE Verts/ALE
67

Luxembourg Verts/ALE

Against (1)

1

Czechia Verts/ALE

3

Lithuania Verts/ALE

2

Ireland Verts/ALE

2

Italy Verts/ALE

3

Austria Verts/ALE

3

Belgium Verts/ALE

3

Denmark Verts/ALE

2

Finland Verts/ALE

3

Sweden Verts/ALE

3

Netherlands Verts/ALE

3

Portugal Verts/ALE

Against (1)

1

Poland Verts/ALE

Against (1)

1

Romania Verts/ALE

Against (1)

1

Spain Verts/ALE

4
icon: Renew Renew
90

Hungary Renew

Against (1)

1

Latvia Renew

Against (1)

1

Estonia Renew

3

Luxembourg Renew

Against (1)

1

Slovakia Renew

3

Croatia Renew

Against (1)

1

Lithuania Renew

Against (1)

1

Slovenia Renew

Against (1)

1

Ireland Renew

2

Italy Renew

Against (2)

2

Austria Renew

Against (1)

1

Greece Renew

Against (1)

1

Finland Renew

3

Bulgaria Renew

3

Sweden Renew

3
icon: S&D S&D
124

S&D

Against (1)

1

Latvia S&D

Against (1)

1

Estonia S&D

2

Cyprus S&D

Against (1)

1

Luxembourg S&D

Against (1)

1

Czechia S&D

Against (1)

1

Lithuania S&D

2

Slovenia S&D

2
3

Belgium S&D

2

Greece S&D

Against (1)

1

Finland S&D

Against (1)

1
icon: PPE PPE
153

Hungary PPE

Against (1)

1

Latvia PPE

3

Malta PPE

Against (1)

1

Estonia PPE

Against (1)

1

Cyprus PPE

2

Luxembourg PPE

2

Czechia PPE

Abstain (1)

4

Slovakia PPE

3

Lithuania PPE

3

Slovenia PPE

4

B9-0258/2023 - § 10, après le point p - Am 8 #

2023/06/01 Outcome: -: 452, +: 107, 0: 51
HU AT CZ ?? IT LV EE MT CY LU SK IE HR LT SI FI BE DK EL BG SE NL PT PL FR RO ES DE
Total
19
16
18
1
60
7
7
5
5
5
12
12
11
10
7
13
20
13
12
16
21
25
20
49
68
29
51
78
icon: ID ID
57
3

Czechia ID

2

Estonia ID

For (1)

1

Denmark ID

For (1)

1
icon: ECR ECR
61

Latvia ECR

Abstain (1)

1

Slovakia ECR

For (1)

1

Croatia ECR

Abstain (1)

1

Lithuania ECR

Abstain (1)

1

Finland ECR

2

Greece ECR

Abstain (1)

1

Bulgaria ECR

2

Sweden ECR

Abstain (1)

3

Netherlands ECR

4

Romania ECR

Abstain (1)

1

Germany ECR

Abstain (1)

1
icon: NI NI
30

Latvia NI

1

Slovakia NI

2

Croatia NI

Abstain (1)

2

Lithuania NI

1

Greece NI

Against (1)

1

Netherlands NI

Against (1)

1

France NI

2

Germany NI

Against (1)

1
icon: The Left The Left
29

Cyprus The Left

2

Ireland The Left

3

Finland The Left

Against (1)

1

Belgium The Left

Against (1)

1

Denmark The Left

Against (1)

1

Sweden The Left

Against (1)

1

Germany The Left

3
icon: Verts/ALE Verts/ALE
66

Austria Verts/ALE

3

Czechia Verts/ALE

3

Italy Verts/ALE

3

Luxembourg Verts/ALE

Against (1)

1

Ireland Verts/ALE

2

Lithuania Verts/ALE

2

Finland Verts/ALE

3

Belgium Verts/ALE

3

Denmark Verts/ALE

2

Sweden Verts/ALE

3

Netherlands Verts/ALE

3

Portugal Verts/ALE

Against (1)

1

Poland Verts/ALE

Against (1)

1

Romania Verts/ALE

Against (1)

1

Spain Verts/ALE

4
icon: Renew Renew
90

Hungary Renew

2

Austria Renew

Against (1)

1

Italy Renew

Against (2)

2

Latvia Renew

Against (1)

1

Estonia Renew

3

Luxembourg Renew

Against (1)

1

Slovakia Renew

3

Ireland Renew

2

Croatia Renew

Against (1)

1

Lithuania Renew

Against (1)

1

Slovenia Renew

Against (1)

1

Finland Renew

3

Greece Renew

Against (1)

1

Bulgaria Renew

3

Sweden Renew

3
icon: PPE PPE
151

Czechia PPE

Against (1)

Abstain (1)

4

Latvia PPE

3

Estonia PPE

Against (1)

1

Malta PPE

Against (1)

1

Cyprus PPE

2

Luxembourg PPE

2

Slovakia PPE

3

Lithuania PPE

3

Slovenia PPE

4
icon: S&D S&D
126
3

Czechia S&D

Against (1)

1

S&D

Against (1)

1

Latvia S&D

Against (1)

1

Estonia S&D

2

Cyprus S&D

Against (1)

1

Luxembourg S&D

Against (1)

1

Lithuania S&D

2

Slovenia S&D

2

Finland S&D

Against (1)

1

Belgium S&D

2

Greece S&D

Against (1)

1

B9-0258/2023 - § 36 - Am 10 #

2023/06/01 Outcome: -: 462, +: 95, 0: 59
HU ?? CZ LV EE SI MT CY LU SK LT IE HR IT AT DK EL BE FI BG NL SE PT FR PL RO ES DE
Total
19
1
18
7
7
7
5
5
5
12
10
12
11
61
16
13
12
21
13
16
25
21
20
68
49
29
53
80
icon: ID ID
58

Czechia ID

2

Estonia ID

For (1)

1
3

Denmark ID

For (1)

1
icon: ECR ECR
62

Latvia ECR

Abstain (1)

1

Slovakia ECR

For (1)

1

Lithuania ECR

1

Croatia ECR

Abstain (1)

1

Greece ECR

Abstain (1)

1

Finland ECR

Abstain (1)

2

Bulgaria ECR

2

Sweden ECR

3

Romania ECR

Abstain (1)

1

Germany ECR

Abstain (1)

1
icon: NI NI
32

Latvia NI

1

Slovakia NI

2

Lithuania NI

1

Croatia NI

Abstain (1)

2

Greece NI

Against (1)

1

Belgium NI

Against (1)

1

Netherlands NI

Against (1)

1

France NI

2

Germany NI

Against (1)

1
icon: The Left The Left
29

Cyprus The Left

2

Ireland The Left

3

Denmark The Left

Against (1)

1

Belgium The Left

Against (1)

1

Finland The Left

Against (1)

1

Sweden The Left

Against (1)

1

Germany The Left

3
icon: Verts/ALE Verts/ALE
67

Czechia Verts/ALE

3

Luxembourg Verts/ALE

Against (1)

1

Lithuania Verts/ALE

2

Ireland Verts/ALE

2

Italy Verts/ALE

3

Austria Verts/ALE

3

Denmark Verts/ALE

2

Belgium Verts/ALE

3

Finland Verts/ALE

3

Netherlands Verts/ALE

3

Sweden Verts/ALE

3

Portugal Verts/ALE

Against (1)

1

Poland Verts/ALE

Against (1)

1

Romania Verts/ALE

Against (1)

1

Spain Verts/ALE

4
icon: Renew Renew
90

Hungary Renew

2

Latvia Renew

Against (1)

1

Estonia Renew

3

Slovenia Renew

Against (1)

1

Luxembourg Renew

Against (1)

1

Slovakia Renew

3

Lithuania Renew

Against (1)

1

Ireland Renew

2

Croatia Renew

Against (1)

1

Italy Renew

Against (2)

2

Austria Renew

Against (1)

1

Greece Renew

Against (1)

1

Finland Renew

3

Bulgaria Renew

3

Sweden Renew

3
icon: S&D S&D
126

S&D

Against (1)

1

Czechia S&D

Against (1)

1

Latvia S&D

Against (1)

1

Estonia S&D

2

Slovenia S&D

2

Cyprus S&D

Against (1)

1

Luxembourg S&D

Against (1)

1

Lithuania S&D

2
3

Greece S&D

Against (1)

1

Belgium S&D

2

Finland S&D

Against (1)

1
icon: PPE PPE
152

Latvia PPE

3

Estonia PPE

Against (1)

1

Slovenia PPE

For (1)

4

Malta PPE

Against (1)

1

Cyprus PPE

2

Luxembourg PPE

2

Slovakia PPE

3

Lithuania PPE

3

B9-0258/2023 - § 52 #

2023/06/01 Outcome: +: 537, -: 62, 0: 16
DE ES PL FR RO NL PT HU SE CZ IT BG BE FI AT IE DK EL LT SK HR LV SI EE MT CY LU ??
Total
80
52
49
68
29
26
20
18
21
18
60
16
21
13
16
12
13
14
10
12
10
7
7
7
5
5
5
1
icon: PPE PPE
151

Croatia PPE

Against (1)

4

Estonia PPE

For (1)

1

Malta PPE

For (1)

1

Cyprus PPE

2

Luxembourg PPE

2
icon: S&D S&D
125

Czechia S&D

For (1)

1

Belgium S&D

2

Finland S&D

1

Greece S&D

1

Lithuania S&D

2

Latvia S&D

For (1)

1

Slovenia S&D

2

Estonia S&D

2

Cyprus S&D

1

Luxembourg S&D

For (1)

1

S&D

For (1)

1
icon: Renew Renew
91

Hungary Renew

2
3

Italy Renew

2

Finland Renew

3

Austria Renew

For (1)

1

Ireland Renew

2

Greece Renew

1

Lithuania Renew

1

Slovakia Renew

3

Croatia Renew

For (1)

1

Latvia Renew

For (1)

1

Slovenia Renew

For (1)

1

Estonia Renew

3

Luxembourg Renew

For (1)

1
icon: Verts/ALE Verts/ALE
67

Poland Verts/ALE

For (1)

1

Romania Verts/ALE

1

Netherlands Verts/ALE

3

Portugal Verts/ALE

1

Sweden Verts/ALE

3

Czechia Verts/ALE

3

Italy Verts/ALE

3

Belgium Verts/ALE

3

Finland Verts/ALE

3

Austria Verts/ALE

3

Ireland Verts/ALE

2

Denmark Verts/ALE

2

Lithuania Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1
icon: ECR ECR
62

Germany ECR

1

Romania ECR

Abstain (1)

1

Sweden ECR

For (1)

3

Bulgaria ECR

2

Greece ECR

1

Lithuania ECR

1

Slovakia ECR

Abstain (1)

1

Croatia ECR

1

Latvia ECR

For (1)

1
icon: The Left The Left
29

Germany The Left

Against (1)

3

Sweden The Left

For (1)

1

Belgium The Left

For (1)

1

Finland The Left

For (1)

1

Ireland The Left

3

Denmark The Left

1

Cyprus The Left

2
icon: NI NI
32

Germany NI

1

France NI

2

Netherlands NI

Against (1)

1

Belgium NI

For (1)

1

Lithuania NI

1

Slovakia NI

2

Croatia NI

Abstain (1)

1

Latvia NI

1
icon: ID ID
58

Czechia ID

For (1)

Abstain (1)

2

Austria ID

3

Denmark ID

Abstain (1)

1

Estonia ID

Abstain (1)

1

B9-0258/2023 - Proposition de résolution (ensemble du texte) #

2023/06/01 Outcome: +: 525, 0: 33, -: 2
DE FR IT ES PL RO NL SE CZ PT BE HU BG FI DK EL SK LT IE HR AT LV EE LU SI MT CY ??
Total
75
64
53
46
43
27
23
20
18
18
19
16
13
12
12
12
11
10
10
10
17
6
7
5
4
4
4
1
icon: PPE PPE
139

Estonia PPE

For (1)

1

Luxembourg PPE

2

Slovenia PPE

2

Malta PPE

For (1)

1

Cyprus PPE

For (1)

1
icon: S&D S&D
112

Czechia S&D

For (1)

1

Belgium S&D

2

Finland S&D

1

Greece S&D

1

Lithuania S&D

2

Latvia S&D

For (1)

1

Estonia S&D

2

Luxembourg S&D

For (1)

1

Slovenia S&D

For (1)

1

Cyprus S&D

1

S&D

For (1)

1
icon: Renew Renew
86

Italy Renew

2
3

Hungary Renew

2

Finland Renew

3

Slovakia Renew

3

Lithuania Renew

1

Ireland Renew

2

Croatia Renew

For (1)

1

Austria Renew

For (1)

1

Latvia Renew

For (1)

1

Estonia Renew

3

Luxembourg Renew

For (1)

1

Slovenia Renew

For (1)

1
icon: Verts/ALE Verts/ALE
64

Italy Verts/ALE

3

Spain Verts/ALE

3

Poland Verts/ALE

For (1)

1

Romania Verts/ALE

1

Netherlands Verts/ALE

3

Sweden Verts/ALE

3

Czechia Verts/ALE

3

Portugal Verts/ALE

1

Belgium Verts/ALE

3

Finland Verts/ALE

2

Denmark Verts/ALE

2

Lithuania Verts/ALE

2

Ireland Verts/ALE

1

Austria Verts/ALE

3

Luxembourg Verts/ALE

For (1)

1
icon: ECR ECR
50

Romania ECR

Abstain (1)

1

Netherlands ECR

4

Sweden ECR

For (1)

3

Belgium ECR

2

Bulgaria ECR

2

Greece ECR

1

Slovakia ECR

For (1)

1

Lithuania ECR

1

Croatia ECR

1
icon: ID ID
52

Czechia ID

2

Denmark ID

Abstain (1)

1

Austria ID

3

Estonia ID

Abstain (1)

1
icon: The Left The Left
28

Germany The Left

3

Sweden The Left

For (1)

1

Belgium The Left

For (1)

1

Finland The Left

For (1)

1

Ireland The Left

3

Cyprus The Left

2
icon: NI NI
29

Germany NI

1

France NI

For (1)

1

Netherlands NI

Against (1)

1

Belgium NI

For (1)

1

Slovakia NI

Abstain (1)

1

Lithuania NI

1

Croatia NI

Abstain (1)

2

Latvia NI

1

History

(these mark the time of scraping, not the official date of the change)

docs/2
date
2023-06-01T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2023-0220_EN.html title: T9-0220/2023
type
Text adopted by Parliament, single reading
body
EP
events/1/summary
  • The European Parliament adopted by 525 votes to 2, with 33 abstentions, a resolution on EU action to combat antimicrobial resistance.
  • The text adopted in plenary was tabled by the EPP, S&D, Renew, Greens/EFA, ECR and the Left groups.
  • Context
  • In 2022, the Commission, together with the Member States, identified antimicrobial resistance (AMR) as one of the top three priority health threats in the EU. It is estimated that more than 35 000 people in the EU/EEA and more than 1.2 million people globally die each year as a direct consequence of an infection due to bacteria resistant to antibiotics. The health impact of AMR is comparable to that of influenza, tuberculosis and HIV/AIDS combined and the trends in the latest data show a significant increase in the number of infections and attributable deaths for almost all bacterium-antibiotic resistance combinations, especially in healthcare settings, where around 70 % of cases of infections with antibiotic-resistant bacteria were healthcare-associated infections.
  • If no further action is taken, the global AMR death toll by 2050 could reach more than 10 million annually, higher than the expected number of deaths from cancer and diabetes combined and could cause economic damage as catastrophic as the 2008-2009 global financial crisis.
  • Although AMR affects the Member States differently, action at EU level to address AMR can deliver clear added value, since no single Member State alone can provide an adequate solution to this cross-border and global issue.
  • Recommendations
  • Parliament is convinced that AMR requires a multi-faceted strategy in the EU, based on the One Health approach. It welcomed the Commission’s proposal for a Council recommendation on stepping up EU measures to combat antimicrobial resistance based on the One Health approach and called on the Council to adopt a recommendation taking this resolution into account as a way to step up action in areas complementing legislation under the proposed pharmaceuticals package. The resolution recalled however that powers to adopt binding Union acts in the field of health remain subject to the ordinary legislative procedure. Therefore, Parliament takes the view that should measures achieved under a recommendation be insufficient, further legislative action at EU level will be needed.
  • The resolution stressed that addressing AMR successfully requires a three-pronged approach combining prudent use of antibiotics for humans and animals, implementing good infection prevention and control measures, especially in healthcare settings and promoting research and development into novel antimicrobials and alternatives to antimicrobials.
  • National action plans against AMR
  • Parliament called on Member States to put in place, publicise and implement a national action plan against AMR (NAP), based on the One Health approach and in line with the objectives of the World Health Organization Global Action Plan and the 2016 Declaration of the United Nations high-level meeting of the General Assembly on AMR by 1 March 2024, and regularly update such the National Action Plans. Member States should ensure that appropriate and sufficient human and financial resources should be allocated for the effective implementation of the NAP.
  • Surveillance and monitoring of AMR and antimicrobial consumption (AMC)
  • Member States should close existing surveillance and monitoring gaps and ensure the completeness of the data, including real-time data where appropriate, by 2030, both on AMR and AMC at all levels (such as in the community, hospitals and long-term care facilities) to support the prudent use of antimicrobials in human health.
  • Infection prevention and control, and water, sanitation and hygiene
  • Parliament called on the Member States to ensure that infection prevention and control measures in human health are implemented and continuously monitored to contribute to limiting the spread of antimicrobial resistant pathogens in particular by strengthening infection prevention and control and improving WASH, environmental cleaning and waste management in healthcare settings and long-term care facilities and upgrading existing hospital infrastructure and human resources.
  • Moreover, measures should be taken to improve the health and welfare of food-producing animals to decrease the occurrence and spread of infectious diseases in farming. In this regard, the Commission is called on to put forward a proposal for the revision of EU legislation on farm animal welfare.
  • Parliament insisted that EU infection prevention and control guidelines in human health, notably for hospitals and long-term care facilities need to be put in place by 1 June 2026.
  • Antimicrobial stewardship and prudent use of antimicrobials
  • Parliament called on the Member States to ensure that human-health measures are implemented to support the prudent use of antimicrobial agents, inter alia by: (i) implementing EU guidelines for the treatment of common infections and for perioperative prophylaxis and adapting these guidelines to national circumstances, where necessary, in order to adhere to best practices and optimise the prudent use of antimicrobials; (ii) where possible, restricting antibiotic prescription to face-to-face consultations.
  • Member States are called on to put in place programmes for the collection and safe disposal of unused, expired and leftover antimicrobials from the community, hospitals and long-term care facilities, farms, veterinary medicine providers, and production facilities, and ensure that the public can make use of these disposal facilities via a local healthcare facility.
  • The Commission should work towards the development of EU guidelines for the treatment of major common infections in humans and for perioperative prophylaxis in humans.
  • Recommended targets for antimicrobial consumption and antimicrobial resistance
  • Member States are called on to take national measures to ensure that by 2030:
  • - the total consumption of antibiotics by humans (in terms of the defined daily dose (DDD) per 1 000 inhabitants), in the community and hospital sectors combined, including in long-term care facilities, is reduced by 20 % in the EU compared with the baseline year 2019 with a highest DDD of 15 in any Member State;
  • - at least 70 % of the total human consumption of antibiotics belongs to the Access group of antibiotics, as defined in the WHO’s AWaRe classification;
  • - the total incidence of bloodstream infections with methicillin-resistant Staphylococcus aureus (MRSA) (per 100 000 population) is reduced by 15 % in the EU, compared to the baseline year 2019;
  • - the total incidence of bloodstream infections with third generation cephalosporin-resistant Escherichia coli (per 100 000 population) is reduced by 10 % in the EU, compared to the baseline year 2019;
  • - the total incidence of bloodstream infections with carbapenem-resistant Klebsiella pneumoniae (per 100 000 population) is reduced by 5 % in the EU, compared to the baseline year 2019.
  • Research and development
  • Parliament called on the Member States and the Commission to:
  • - support research data sharing and technological innovation for the detection, prevention and treatment of infections in humans caused by antimicrobial resistant pathogens, including the establishment of, and significant investment in, a European partnership to allow coordination, alignment and funding of cross-sector research and innovation on ‘One Health AMR’;
  • - pool resources, run collaborative initiatives, financially contribute to the implementation of the pull incentive scheme, and undertake to participate in the network referred to under the EU4Health work programme 2023;
  • - incentivise the development and placing on the market of alternatives to antimicrobials, as well as innovative diagnostic tests and vaccines for animal health and alternatives to antimicrobials, such as local anaesthetics or psychopharmacological drugs, including a design for degradable antibiotics.
  • Reporting
  • The Commission should report to the European Parliament and the Council four years after adoption of this resolution on the progress in its implementation.
docs/2
date
2023-06-01T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2023-0220_EN.html title: T9-0220/2023
type
Text adopted by Parliament, single reading
body
EP
events/0/docs
  • url: https://www.europarl.europa.eu/doceo/document/CRE-9-2023-06-01-TOC_EN.html title: Debate in Parliament
events/1
date
2023-06-01T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2023-0220_EN.html title: T9-0220/2023
procedure/stage_reached
Old
Awaiting plenary debate/vote
New
Procedure completed
procedure/title
Old
Anti-microbial resistance
New
Resolution on EU action to combat antimicrobial resistance
docs/1
date
2023-06-01T00:00:00
docs
title: B9-0022/2023
type
Oral question/interpellation by Parliament
body
EP
events
  • date: 2023-06-01T00:00:00 type: Debate in Parliament body: EP
forecasts
  • date: 2023-06-01T00:00:00 title: Debate in plenary scheduled
forecasts/0
date
2023-06-01T00:00:00
title
Debate in plenary scheduled
forecasts/0
date
2023-05-31T00:00:00
title
Indicative plenary sitting date
docs/0/docs/0/url
https://www.europarl.europa.eu/doceo/document/B-9-2023-0258_EN.html
docs
  • date: 2023-05-24T00:00:00 docs: title: B9-0258/2023 type: Motion for a resolution body: EP
procedure/title
Old
Anti-Microbial resistance
New
Anti-microbial resistance